Kristopher Hanson
CIK 1789970 · General Counsel · last filed 2026-05-11
Kristopher Hanson is a General Counsel who has filed 14 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing shows the insider sold $419.3K of MPLT on May 11, 2026. Across all open-market trades the lifetime net is −$856.6K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.67M
2
14
-$856.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MPLT | General Counsel | 168,139 | $27.75 | $4.67M | -$856.6K | 6 | 2026-05-11 |
| PhaseBio Pharmaceuticals Inc (PHAS) Delisted | SVP and General Counsel | 8,463 | $0.07 | $593 | $0 | 8 | 2022-05-24 |
Recent Filings
14 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-11 | MPLT | Sell (S) | −13,917 | -$419.3K | EDGAR |
| 2026-05-06 | MPLT | Sell (S) | −13,917 | -$388.2K | EDGAR |
| 2026-04-17 | MPLT | Sell (S) | −1,827 | -$49.1K | EDGAR |
| 2026-02-09 | MPLT | Grant (A) | +7,730 | $0 | EDGAR |
| 2026-01-29 | MPLT | Tax (F) | −26,007 | -$467.6K | EDGAR |
| 2025-10-28 | MPLT | Grant (A) | +27,098 | $0 | EDGAR |
| 2022-05-24 | PhaseBio Pharmaceuticals Inc (PHAS) Delisted | Grant (A) | +4,831 | $3.3K | EDGAR |
| 2022-02-28 | PhaseBio Pharmaceuticals Inc (PHAS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-11-23 | PhaseBio Pharmaceuticals Inc (PHAS) Delisted | Grant (A) | +1,545 | $3.1K | EDGAR |
| 2021-05-24 | PhaseBio Pharmaceuticals Inc (PHAS) Delisted | Grant (A) | +1,088 | $3.0K | EDGAR |